Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

99.96 +0.31 (+0.31%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

3 AI Stocks That Should Be on Every Investor’s Radar This Fall ↗

September 20, 2023

These pick-and-shovel AI plays are poised to deliver tremendous returns with rapid sales expansion over the coming years.

Via InvestorPlace

Topics Artificial Intelligence

Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting

September 01, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus to Present at the Wells Fargo Healthcare Conference

August 31, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty

August 03, 2023

Agreement enhances Lantheus’ strong liquidity position and supports continued pipeline advancement and commercial readiness

From Lantheus Holdings, Inc.

Via GlobeNewswire

Analyst Ratings for Lantheus Holdings ↗

June 01, 2023

Via Benzinga

Lantheus Reports Second Quarter 2023 Financial Results

August 03, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time

July 20, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Neogen Stock Shows Market Leadership With Jump To 86 RS Rating ↗

June 21, 2023

On Wednesday, Neogen stock had its Relative Strength (RS) Rating upgraded to 86, up from 80 a day earlier.

Via Investor's Business Daily

Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

June 12, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Holdings's Return On Capital Employed Overview ↗

May 15, 2023

Via Benzinga

Lantheus Holdings Earnings Perspective: Return On Capital Employed ↗

February 27, 2023

Via Benzinga

Why Shares of Lantheus Holdings Rose This Week ↗

February 25, 2023

The company's fourth-quarter and full-year earnings were a pleasant surprise.

Via The Motley Fool

2 Medical Imaging Stocks That Are Better Buys Than Nano-X ↗

June 03, 2023

Both companies are using artificial intelligence to improve their products.

Via The Motley Fool

Lantheus to Present at the Jefferies Healthcare Conference

June 01, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR

May 23, 2023

PYLARIFY success leads to maximum payment in first year

From Lantheus Holdings, Inc.

Via GlobeNewswire

7 Stocks That Wall Street Analysts Are Loving in May ↗

May 21, 2023

Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.

Via InvestorPlace

Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗

May 05, 2023

The major indexes retreated for most of the week on banking fears,

Via Investor's Business Daily

Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday ↗

May 04, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

Why Shares of Lantheus Holdings Are Up Thursday ↗

May 04, 2023

The company reported a record quarter for revenue.

Via The Motley Fool

Lantheus Reports First Quarter 2023 Financial Results

May 04, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

April 24, 2023

From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.

Via GlobeNewswire

Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time

April 20, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Two Key Executive Promotions

March 17, 2023

Paul Blanchfield promoted to President; Dan Niedzwiecki promoted to Chief Administrative Officer

From Lantheus Holdings, Inc.

Via GlobeNewswire

Are These Medical Device Makers Getting Ready To Rally?

March 10, 2023

Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors.

Via MarketBeat

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023 ↗

March 08, 2023

Via Benzinga

Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 23, 2023

Gainers

Via Benzinga

Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday ↗

February 23, 2023

U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Nasdaq Jumps 100 Points; US GDP Rises 2.7% In Q4 ↗

February 23, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.35% to 33,162.00 while the NASDAQ rose 0.91%...

Via Benzinga

Lantheus Shares Jump On Upbeat 2023 Guidance, Q4 Earnings Surpass Expectations ↗

February 23, 2023

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.